Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography Takeshi.

Slides:

Advertisements

Similar presentations

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung Sai-Hong.

Advertisements

Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Leptomeningeal and Medullary Response to Second-Line Erlotinib in Lung Adenocarcinoma Mathilde Wagner, MD, Benjamin Besse, MD, Corinne Balleyguier, MD,

ALK FISH and IHC: You Cannot Have One without the Other

Diffusion-weighted magnetic resonance imaging in preoperative assessment of non– small cell lung cancer Hiroaki Nomori, MD, Yue Cong, MD, Masaru Abe,

Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer Ernest Nadal,

Epidermal Growth Factor Receptor Mutations: Effect on Volume Doubling Time of Non– Small-Cell Lung Cancer Patients Ryota Nakamura, MD, Yoshihisa Inage,

Incidence and Survival of Malignant Pleural Mesothelioma in Norway: A Population- Based Study of 1686 Cases Åslaug Helland, MD, PhD, Steinar Solberg,

Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients.

Electronic Updates for JTO Readers

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer Hiroyasu Kaneda, MD, PhD, Isamu.

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Dynamic computed tomography to determine cardiac output in patients with left ventricular assist devices Subha V. Raman, MD, MSEE, Tam Tran, BS, Orlando.

Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease Michael Bousamra, MD, Erin Schumer, MS, MD,

Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.

A Severe Photosensitivity Dermatitis Caused by Crizotinib

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal.

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review Arianna Casagrande, MD, Federica Pederiva,

Lung Cancer Producing Granulocyte Colony-Stimulating Factor and Rapid Spreading to Peritoneal Cavity Kyoichi Kaira, MD, PhD, Takahiro Ishizuka, MD, PhD,

The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after.

Prospective Study on Functional Results After Lung-Sparing Radical Pleurectomy in the Management of Malignant Pleural Mesothelioma Servet Bölükbas, MD,

Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung Cancer Jianlin Xu, MD, Haitang Yang, MD, Xiaolong Fu, MD, Bo Jin,

Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.

A Prognostic Model to Predict Mortality among Non–Small-Cell Lung Cancer Patients in the U.S. Military Health System Jie Lin, PhD, MPH, Corey A. Carter,

Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E

Imaging Requirements in the Practice of Pulmonary Metastasectomy

Relationship Between Functional Preservation after Segmentectomy and Volume- Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients.

Solitary Choriocarcinoma in the Lung

Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller Yangki Seok,

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

PET/CT Findings for Bone Marrow Carcinosis Because of Lung Adenocarcinoma Keisuke Watanabe, MD, Masaharu Shinkai, MD, PhD, Kenjiro Nagai, MD, Nobuhiro.

Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed Emanuela Taioli, MD, PhD, Raja Flores, MD

Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.

Required area of lymph node sampling during segmentectomy for clinical stage IA non– small cell lung cancer Hiroaki Nomori, MD, PhD, Yasuomi Ohba, MD,

Pulmonary Metastases from Cervical Adenocarcinoma Regress to a ‘Hole’ Lot of Nothing Michael Guandalini, MBBS (Hons), BPhty, Karin Steinke, MD, MS, PD,

Mirror Mirror on the Wall, Who Is the Fairest of Them All

Combined Serum Mesothelin and Plasma Osteopontin Measurements in Malignant Pleural Mesothelioma Alfonso Cristaudo, MD, Alessandra Bonotti, PhD, Silvia.

Matthew Reichert, MD, Eric S. Bensadoun, MD

Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant? Daniel J. Tandberg,

A Retrospective Analysis of Clinical Outcomes of Patients Older Than or Equal to 80 Years with Small Cell Lung Cancer Toshiyuki Noguchi, MD, Hideaki.

Pulmonary Metastasectomy in Breast Cancer

Nicholas W. Choong, MD, Robert S. Hellman, MD

Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma Zacariah E. Labby, PhD, Samuel G. Armato, PhD,

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

Pulmonary Resection for Metastases from Colorectal Cancer

Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local.

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Marianna Koczywas, MD, Mihaela C. Cristea, MD

Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi, MD, PhD,

Clinical and Pathological Staging Validation in the Eighth Edition of the TNM Classification for Lung Cancer: Correlation between Solid Size on Thin-Section.

European Lung Cancer Conference (ELCC) 2016 Organisation

Metastatic Lung Cancer to the Pancreas

False-Positive FDG-PET and Bronchial Anthracofibrosis

S-1 Treatment for Chemorefractory Thymic Carcinoma

Follow-Up of Small (4 mm or Less) Incidentally Detected Nodules by Computed Tomography in Oncology Patients: A Retrospective Review Reginald F. Munden,

Role of Positron Emission Tomography/Computed Tomography Findings for Adjuvant Chemotherapy Indications in Stage T1b-2aN0M0 Lung Adenocarcinoma Shinsuke.

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma Hirofumi Uehara, MD,

Disease-Free Interval Length Correlates to Prognosis of Patients Who Underwent Metastasectomy for Esophageal Lung Metastases Satoshi Shiono, MD, Masafumi.

Who should decide margin length in pulmonary excision of lung cancer?

Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy Matthew S. Block, MD, PhD, Robert Vassallo,

Super Scan Using Positron Emission Tomography in Lung Cancer Patients

Farhood Farjah, MD, MPH, David R. Flum, MD, MPH, Scott D

Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell.

Presentation transcript:

Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography Takeshi Mori, MD, PhD, Hiroaki Nomori, MD, PhD, Koei Ikeda, MD, PhD, Koichi Kawanaka, MD, Shinya Shiraishi, MD, PhD, Kazuhiro Katahira, MD, PhD, Yasuyuki Yamashita, MD, PhD Journal of Thoracic Oncology Volume 3, Issue 4, Pages 358-364 (April 2008) DOI: 10.1097/JTO.0b013e318168d9ed Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 CT image (A), positron emission tomography image (B), and diffusion-weighted image (C) of lung cancer patient. Journal of Thoracic Oncology 2008 3, 358-364DOI: (10.1097/JTO.0b013e318168d9ed) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 The receiver operating characteristics curve of ADC-min value for diagnosing malignancy for pulmonary nodules/masses showing the optimal cutoff value to be 1.1 × 10−3 mm2/s. Area under curve: 0.907 (95% confidence interval: 0.846–0.968). Journal of Thoracic Oncology 2008 3, 358-364DOI: (10.1097/JTO.0b013e318168d9ed) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 The receiver operating characteristics curve of SUV-CR for diagnosing malignancy for pulmonary nodules/masses showing the optimal cutoff value to be 0.37. Area under curve: 0.806 (95% confidence interval: 0.710–0.901). Journal of Thoracic Oncology 2008 3, 358-364DOI: (10.1097/JTO.0b013e318168d9ed) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 4 Correlation plots between ADC-min and SUV-CR. Open circle shows malignant and closed circle shows benign nodule/mass. Dotted lines show cutoff value for ADC-min and SUV-CR. The solid line shows the linear regression line and the broken lines show 95% confidence interval. ADC-min = minimum apparent diffusion coefficient; SUV-CR = contrast ratio of standard uptake value. Journal of Thoracic Oncology 2008 3, 358-364DOI: (10.1097/JTO.0b013e318168d9ed) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions